Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients

被引:68
作者
Ohtoshi, K
Kaneto, H [1 ]
Node, K
Nakamura, Y
Shiraiwa, T
Matsuhisa, M
Yamasaki, Y
机构
[1] Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Osaka, Japan
[2] Saga Univ, Dept Cardiovasc & Renal Med, Saga 840, Japan
关键词
diabetes insulin resistance; euglycemic hyperinsulinemic clamp; soluble epoxide hydrolase; polymorphism;
D O I
10.1016/j.bbrc.2005.03.171
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The insulin resistance found in diabetes is influenced by vascular tone and local blood flow. Endothelial-derived hyperpolarizing factor (EDHF) functions as a potent vasodilator to regulate vascular tone, and its production is regulated by soluble epoxide hydrolase (sEH). In this study, we examined the genotype distribution and allele frequency of sEH gene G860A (Arg287GIn) polymorphism in Japanese subjects (n = 499) (non-diabetic subjects, n = 205; type 2 diabetic patients, n = 294). Also, to accurately evaluate insulin resistance, we performed the euglycemic hyperinsulinemic clamp test for each type 2 diabetic patient (n = 86) from whom agreement was obtained, and then examined a possible association of sEH gene G860A polymorphism with insulin resistance status. There was no significant difference in genotype distribution and allele frequency between non-diabetic subjects and type 2 diabetic patients. Interestingly, however, there was close association of sEH gene G860A (Arg287GIn) polymorphism with insulin resistance in type 2 diabetic patients. which was not observed in non-diabetic subjects. These results suggest that sEH and EDHF play some important role in the pathogenesis of insulin resistance found in type 2 diabetes. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:347 / 350
页数:4
相关论文
共 17 条
[11]   Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms [J].
Sandberg, M ;
Hassett, C ;
Adman, ET ;
Meijer, J ;
Omiecinski, CJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) :28873-28881
[12]   Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2 [J].
Spiecker, M ;
Darius, H ;
Hankeln, T ;
Soufi, M ;
Sattler, AM ;
Schaefer, JR ;
Node, K ;
Börgel, J ;
Mügge, A ;
Lindpaintner, K ;
Huesing, A ;
Maisch, B ;
Zeldin, DC ;
Liao, JK .
CIRCULATION, 2004, 110 (15) :2132-2136
[13]   Polymorphisms in human soluble epoxide hydrolase: effects on enzyme activity, enzyme stability, and quaternary structure [J].
Srivastava, PK ;
Sharma, VK ;
Kalonia, DS ;
Grant, DF .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2004, 427 (02) :164-169
[14]   Obesity/insulin resistance is associated with endothelial dysfunction - Implications for the syndrome of insulin resistance [J].
Steinberg, HO ;
Chaker, H ;
Leaming, R ;
Johnson, A ;
Brechtel, G ;
Baron, AD .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) :2601-2610
[15]   Inhibition of vascular smooth muscle cell migration by cytochrome P450 epoxygenase-derived eicosanoids [J].
Sun, JX ;
Sui, XX ;
Bradbury, JA ;
Zeldin, DC ;
Conte, MS ;
Liao, JK .
CIRCULATION RESEARCH, 2002, 90 (09) :1020-1027
[16]   Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids [J].
Weintraub, NL ;
Fang, X ;
Kaduce, TL ;
VanRollins, M ;
Chatterjee, P ;
Spector, AA .
CIRCULATION RESEARCH, 1997, 81 (02) :258-267
[17]   Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids [J].
Yu, ZG ;
Xu, FY ;
Huse, LM ;
Morisseau, C ;
Draper, AJ ;
Newman, JW ;
Parker, C ;
Graham, L ;
Engler, MM ;
Hammock, BD ;
Zeldin, DC ;
Kroetz, DL .
CIRCULATION RESEARCH, 2000, 87 (11) :992-998